Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 05, 2026
Why Did SES AI Corporation (SES) Stock Fall -30.41% Today?

Why Did SES AI Corporation (SES) Stock Fall -30.41% Today?

Key Takeaways

  • SES shares are down approximately 30% intraday on Thursday, March 5, 2026, trading near $1.19 against the prior session's close of $1.71
  • The primary catalyst is deeply disappointing 2026 revenue guidance of $30–$35 million — roughly 41% below the Wall Street consensus of $51.67 million
  • Q4 2025 revenue of $4.56 million missed analyst estimates of $6.64 million by 31%, despite a 124% year-over-year increase
  • On the positive side, SES AI beat on EPS — reporting a loss of $0.04 vs. the $0.05 consensus — and ended 2025 with ~$200 million in liquidity, enough to fund operations into 2028
  • The stock has broken decisively below its 20-day, 50-day, and 200-day simple moving averages, worsening the technical picture
  • Volume is sharply elevated; traders are now focused on execution in the ESS, drone battery, and Molecular Universe segments as key 2026 indicators

Opening Summary

SES AI Corporation (SES) is a Woburn, Massachusetts-based developer of AI-enhanced lithium-metal and lithium-ion batteries and an AI-for-science software platform called Molecular Universe, targeting electric vehicle, drone, robotics, and energy storage markets. On Thursday, March 5, 2026, shares are down approximately 30% intraday, trading near $1.19, compared to the prior session's closing price of $1.71. The selloff is a direct reaction to the company's Q4 and full-year 2025 earnings report, released after the close on March 4, which included a quarterly revenue miss and 2026 guidance that fell dramatically short of analyst expectations.

Q4 2025 Earnings: Beat on Profit, Miss on Revenue

SES AI's fourth-quarter results delivered a split verdict that the market ultimately judged negatively. The company reported an adjusted loss of $0.04 per share, beating the analyst consensus of $0.05 and a significant improvement from the $0.11 loss recorded a year earlier. However, Q4 2025 revenue came in at $4.56 million — up 124% year-over-year but 31% below the consensus estimate of $6.64 million — with management citing $1.5 million in revenue pushed into Q1 2026 due to logistics constraints. For the full year, SES grew revenue tenfold to $21.0 million from $2.0 million in 2024, while ending the year with approximately $200 million in liquidity.

Guidance Shock: The Core Catalyst

The single most damaging element driving today's selloff is SES AI's 2026 annual revenue guidance. Management guided for $30 million to $35 million in full-year 2026 revenue — a projection that trails the Wall Street consensus estimate of $51.67 million by approximately 41%. Some analyst estimates placed the consensus even higher at $57.55 million, making the guidance miss even more pronounced. Investors who had priced in a sharp acceleration of the company's commercialization ramp across its Energy Storage Systems, drone battery, and Molecular Universe units responded by aggressively unwinding positions, sending the stock to multi-month lows.

Management's Message vs. Market Reaction

CEO Qichao Hu pointed to the expanding capabilities of the Molecular Universe AI platform, the capex-light operating model, and strong momentum in enterprise and materials verticals as indicators of longer-term health. The company also highlighted the acquisition of Shenzhen UZ Energy, a premium ESS provider that management says positions SES to tap into the $300 billion global energy storage market. Despite these strategic positives and the healthy liquidity runway, investors largely set those factors aside, focusing instead on the near-term revenue miss and the wide gap between guidance and expectations.

Market Context and Trading Activity

Volume on March 5 has surged well above average as investors reacted swiftly to the overnight earnings release, producing a high-conviction, one-directional decline from the opening bell. SES has broken decisively below its 20-day, 50-day, and 200-day simple moving averages — a technically significant event that often triggers additional selling from systematic and rule-based strategies. The broader market showed no comparable pressure today, confirming this is a company-specific, earnings-driven selloff rather than a macro or sector-wide event. The move has erased a significant portion of the stock's dramatic surge from a low of $0.40 to a peak of $3.54 during late 2025.

Trending AI Robots

For traders navigating sharp, earnings-driven dislocations like the one seen in SES today, Tickeron's Trending AI Robots page offers a curated set of the platform's best-performing AI trading bots under current market conditions. Tickeron operates hundreds of AI-powered bots spanning thousands of tickers, each varying by strategy, timeframe, performance metrics, and the symbols they trade — but only the top performers in the prevailing environment earn a spot on the Trending list. Whether your focus is momentum, mean reversion, or sector rotation, the Trending AI Robots section can serve as a practical starting point for identifying which automated strategies are working right now. Explore the page to find a bot aligned with your trading style and risk tolerance.

What Comes Next for SES

Investors will scrutinize SES's Q1 2026 results for confirmation that the $1.5 million in deferred Q4 revenue was recognized, and for evidence that the ESS and drone battery pipelines are converting into bookings at the pace management described. The full-year 2026 guidance range of $30–$35 million now serves as the de facto benchmark — any upward revision would likely be a significant positive catalyst, while a further reduction could extend the selloff. Analyst sentiment is currently mixed, with a consensus "Hold" rating, and the stock's technical picture has deteriorated sharply following today's breakdown below all major moving averages. Broader sector developments in lithium batteries, drone infrastructure, and AI-for-science, along with any new partnership or licensing announcements tied to Molecular Universe, will also be closely watched in the weeks ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitation

Related Ticker: SES

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for SES turns positive, indicating new upward trend

SES saw its Momentum Indicator move above the 0 level on September 23, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned positive. In 75 of the 89 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for SES crossed bullishly above the 50-day moving average on September 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Following a +7.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where SES advanced for three days, in 183 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

SES moved below its 50-day moving average on September 22, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SES declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

SES broke above its upper Bollinger Band on September 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.106) is normal, around the industry mean (7.080). P/E Ratio (0.000) is within average values for comparable stocks, (72.284). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.483). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.237) is also within normal values, averaging (49.084).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. SES’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SES’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are AutoZone (NYSE:AZO), Advance Auto Parts (NYSE:AAP), Goodyear Tire & Rubber Company (The) (NASDAQ:GT).

Industry description

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

Market Cap

The average market capitalization across the Auto Parts: OEM Industry is 4.99B. The market cap for tickers in the group ranges from 1.93K to 69.49B. ORLY holds the highest valuation in this group at 69.49B. The lowest valued company is CREVF at 1.93K.

High and low price notable news

The average weekly price growth across all stocks in the Auto Parts: OEM Industry was -3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -3%. INVZ experienced the highest price growth at 33%, while MKDW experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Auto Parts: OEM Industry was 3%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 59
Price Growth Rating: 60
SMR Rating: 78
Profit Risk Rating: 88
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
SES
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of gasification technology systems and solutions to the energy and chemical industries

Industry AutoPartsOEM

Industry
Chemicals Specialty
Address
35 Cabot Road
Phone
+1 339 298-8750
Employees
215
Web
https://www.ses.ai
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.
Why Did SES AI Corporation (SES) Stock Fall -30.41% Today?